Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status-United States, 1 January 2020-25 December 2021Article Published on 2022-10-032022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI acute respiratory syndrome adjusted Admission age aRR calculated confidence interval coronavirus coronavirus 2 coronavirus disease COVID-19 death Delta delta variant ECMO extracorporeal membrane oxygenation ICU ICU admission increased risk Infection intensive care invasive ventilation nonpregnant Pregnancy pregnant reproductive respiratory risk risk of death risk ratio SARS-CoV-2 severe COVID-19 severe disease severity symptomatic the United State were assessed women women of reproductive age. [DOI] 10.1093/cid/ciac479 PMC 바로가기
Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West AfricaArticle Published on 2022-10-032022-11-15 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 바이오마커, [키워드] ABO ABO blood grouping ABO blood groups acute respiratory syndrome African anti-SARS-CoV-2 antibody antibodies antibody association Asymptomatic Asymptomatic case Blood Blood Group Clustering comparison Concentration coronavirus coronavirus disease correlations COVID-19 COVID-19 severity cytokine cytokine level decrease discrepancy disease severity Eotaxin Factor genetic background group groups Host identify IL-6 IL-8 immune marker Immune profile immune response individuals Kruskal-Wallis Mann-Whitney U test Mild Multiple Multiplex assay offer participant PCR-confirmed performed phenotype plasma Probing proportion quantification recorded reduced regression analysis significantly Spearman statistically significant symptomatic symptomatic and asymptomatic symptomatic patient tested two-tailed was performed was used West West Africa [DOI] 10.1186/s12916-022-02571-2 PMC 바로가기
Magnitude and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission: A Longitudinal Cohort StudyArticle Published on 2022-10-032022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome confidence interval Contact coronavirus coronavirus 2 cumulative determinant Epidemiology evaluated household household contact household contacts household transmission incidence increased risk increasingly individual Infection infectious viral shedding. Intervention longitudinal magnitude nasal occurred populations Primary outcome reduce respiratory risk of infection RNA SARS-CoV-2 SARS-COV-2 infection specimen Symptom symptom onset symptomatic symptomatic SARS-CoV-2 infection Transmission transmission of SARS-CoV-2 vaccination viral shedding [DOI] 10.1093/cid/ciac545 PMC 바로가기
Prevalence of Positive Rapid Antigen Tests After 7-Day Isolation Following SARS-CoV-2 Infection in College Athletes During Omicron Variant PredominanceArticle Published on 2022-10-032022-11-16 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI age Analysis analyzed Antigen Asymptomatic athlete Case series case sery center college contagious Control determine disease division heterogeneous population individual Infection Isolation omicron outcome positive positive result prevention proportion Rapid rapid antigen test remained representing SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant significantly more Spread subsequent symptom status symptomatic symptomatic infection Test tested variant variants [DOI] 10.1001/jamanetworkopen.2022.37149 PMC 바로가기
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodiesArticle Published on 2022-10-022022-11-15 Journal: Virus research [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome analyzed anti-SARS-CoV-2 antibodies antibody Asymptomatic asymptomatic individual Asymptomatic individuals AUC can be used chemiluminescence chemiluminescence immunoassay chemiluminescent immunoassay clinical comparable coronavirus correlation enrolled evaluated group IgG immune Immunoglobulin in both groups microneutralization NAb NAbs negative RT-PCR neutralization activity neutralization titer Neutralizing antibodies neutralizing antibody participant positive positive serology predict Previously symptomatic Protective protective immunity random reactive RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 patients screened serology Significant significantly higher symptomatic symptomatic individual symptomatic individuals symptomatic patient Symptomatic patients total Ig USA were measured [DOI] 10.1016/j.virusres.2022.198852 PMC 바로가기
Thrombosis risk assessment in patients with congenital thrombophilia during COVID – 19 infectionResearch article Published on 2022-10-012022-10-05 Journal: Thrombosis research [Category] 변종, 유전자 메커니즘, 진단, [키워드] absence ACAnticoagulants addition adjusted age Anticoagulant Anticoagulants Antithrombin Antithrombotic association ATAntithrombin BMIbody mass index body mass index case-control study changes in clinical picture Comorbidities Comorbidity comparable Computed tomography Confirmed COVID-19 infection contribute Corona Virus Disease COVID COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients COVIDCorona Virus Disease Critical CTComputed Tomography D-dimer D-dimer level Deep venous thrombosis Diagnosis Direct oral anticoagulant disease DOACDirect Oral Anticoagulant DVTDeep Venous Thrombosis dysfunction evaluate Factor V Leiden factor VIII FEUFibrinogen Equivalent Fibrinogen Equivalent FII G20210AProthrombin mutation Final FV LeidenFactor V Leiden FVIII FVIIIFactor VIII genetic defect HBSHeparin Binding Site Heparin Binding Site individual Infection LMWHlow molecular weight heparin low molecular weight heparin Mild Odds ratio OROdds Ratio outcome parameter Patient patient group PCR/RFLPpolymerase chain reaction/restriction fragment length polymorphism PEPulmonary Embolism polymerase chain reaction/restriction fragment length polymorphism Prophylaxis Prothrombin mutation Pulmonary embolism receive Result risk risk of COVID-19 serious complication severe COVID-19 significantly significantly increased symptomatic thrombosis thrombotic thrombotic complication thrombotic event Thrombotic events Treatment Unusual Thrombosis UTUnusual Thrombosis Venous Thromboembolism vitamin K antagonist VKAVitamin K antagonist VTEVenous Thromboembolism was performed [DOI] 10.1016/j.thromres.2022.08.020 [Article Type] Research article
COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients스웨덴 소아 종양 및 혈액학 환자의 COVID-19 혈청 유병률 및 임상 양상Article Published on 2022-10-012022-09-12 Journal: Pediatric blood & cancer [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome age analyzed anti-S1 IgM anti-SARS-CoV-2 antibodies antibody blood sample clinical clinical picture Cohort collected coronavirus coronavirus disease COVID-19 cumulative develop Diagnosis disease electronic medical records hematology IgG antibody IgM and IgG immunology Immunosuppressive treatment incidence of COVID-19 increased risk Increasing Infection investigated majority Mild MOST National nine oncology outpatients pandemic Patient patient cohort patients PCR test pediatric pediatrics polymerase chain questionnaire recruited recruitment reported SARS-CoV-2 SARS-COV-2 infection seropositive severe COVID-19 study period Swedish symptomatic Treatment underlying disease Uppsala University vaccination wild-type [DOI] 10.1002/pbc.29773 PMC 바로가기 [Article Type] Article
Pre-vaccination immune response to COVID-19 in a population in Northeast PortugalArticle Published on 2022-10-012022-11-15 Journal: Irish Journal of Medical Science [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome age Analysis antibody application Asymptomatic coronavirus COVID-19 diagnosed Diagnosis exhibited group highest IgG IgM IgM and IgG immune response Immunity immunization individuals initial Laboratory median value participant Participants Patient PCR PCR diagnosis peaked Portugal Protein reported responders RT-PCR SARS-CoV-2 Seronegativity seropositive significant decrease statistically significant study population Symptom symptomatic vaccination [DOI] 10.1007/s11845-021-02799-6 PMC 바로가기
A systematic review and meta-analysis of the IgA seroprevalence in COVID-19 patients: Is there a role for IgA in COVID-19 diagnosis or severity?COVID-19 환자의 IgA 혈청 유병률에 대한 체계적인 검토 및 메타 분석: COVID-19 진단 또는 중증도에서 IgA의 역할이 있습니까?Meta-Analysis Published on 2022-10-012022-09-11 Journal: Microbiological research [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, 치료기술, [키워드] Abstract acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody association asymptomatic patients Biomarker caused coronavirus coronavirus disease COVID-19 COVID-19 diagnosis COVID-19 disease determine diagnostic diagnostic test diagnostic tests disease Efficacy Health health problems Humoral response humoral responses IgA Immunity in some include Infection manuscript Meta-analysis Mild observé Patient problems produced Research respiratory SARS-CoV-2 SARS-CoV-2 PCR Seroprevalence severe acute respiratory syndrome Coronavirus Severe patient severe patients severity susceptibility symptomatic systematic review Vaccines [DOI] 10.1016/j.micres.2022.127105 PMC 바로가기 [Article Type] Meta-Analysis
Acute encephalopathy in a 6-year-old child with concurrent COVID-19 infection: a case report from Saudi ArabiaCase report Published on 2022-10-012022-10-05 Journal: International Journal of Infectious Diseases [Category] 치료기술, 치료제, [키워드] absence Case report Child children clinical outcomes Complication COVID-19 differential diagnosis Encephalopathy Favipiravir Health immunosuppressive therapy impacted knowledge Laboratory manifested maternity morbidities mortality rate neurologic pandemic Patient patient with COVID-19 pediatric Pediatric patients presenting pulse recovered completely reported respiratory manifestations respiratory symptoms routine Saudi Arabia Seizure status epilepticus symptomatic the patient Therapies with COVID-19 [DOI] 10.1016/j.ijid.2022.08.013 [Article Type] Case report